Overview

EPO for Postop Delirium in Elderly Patients

Status:
Completed
Trial end date:
2019-08-28
Target enrollment:
Participant gender:
Summary
Postoperative delirium is a common complication after surgery. The underlying pathophysiology of this complication is unclear, however neuroinflammation and oxidative stress secondary to surgery had shown to be the cause of postoperative cognitive dysfunction and delirium. Erythropoietin represents non-erythropoietic effects of anti-inflammatory properties. The aims of this study were to determine the role of erythropoietin toward the development of postoperative delirium, in terms of changes in inflammatory reaction by affecting the innate immunity in elderly patients undergoing total joint arthroplasty surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Yonsei University
Treatments:
Epoetin Alfa